首页> 外文期刊>Modern Pathology >Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors
【24h】

Stage and histological grade of gastrointestinal stromal tumors based on a new approach are strongly associated with clinical behaviors

机译:基于新方法的胃肠道间质瘤的分期和组织学分级与临床行为密切相关

获取原文
           

摘要

Tumor stage and grade for gastrointestinal stromal tumors are poorly defined. To develop a better evaluation system, we assessed 12 clinical and pathological parameters in 613 patients with follow-up information. These parameters were classified into two gross spread parameters including liver metastasis and peritoneal dissemination, five microscopic spread parameters including lymph node metastasis, vascular, fat, nerve and mucosal infiltration, and five histological parameters including mitotic count ≥10 per 50 high-power fields, muscularis propria infiltration, coagulative necrosis, perivascular pattern and severe nuclear atypia. The 5-year disease-free survival and overall survival of 293 patients without any of these predictive parameters of malignancy were 99 and 100%, respectively. They were regarded as nonmalignant and further evaluations on the stage and grade of these tumors were not performed. At least one and at most seven predictive parameters of malignancy were identified in 320 patients. For these patients, the 5-year disease-free survival and overall survival rates were 44% (mean 6.7 years) and 60% (mean 9.3 years), respectively. The disease-free survival showed significant difference between patients with and without gross spread (PP=0.0009). Disease-free survival and overall survival were associated with the number of predictive parameters of malignancy in patients without gross spread (PP=0.882 and 0.441, respectively). Malignant gastrointestinal stromal tumors could be divided into clinical stage I and II based on the absence and presence of gross spread, respectively. The degree of malignancy of patients in clinical stage I could be graded according to the number of predictive parameters of malignancy. Patients in clinical stage II were of the highest degree of malignancy regardless of the number of parameters. We found that the clinical stage and grade were strongly associated with prognosis.
机译:胃肠道间质瘤的肿瘤分期和等级定义不清。为了建立更好的评估系统,我们对613例患者的12项临床和病理学参数进行了随访。这些参数分为两个总扩散参数,包括肝转移和腹膜扩散;五个微观扩散参数,包括淋巴结转移,血管,脂肪,神经和粘膜浸润;五个组织学参数,包括每50个高倍视野的有丝分裂计数≥10,固有肌层浸润,凝血坏死,血管周围形态和严重的核异型。没有这些恶性预测指标的293例患者的5年无病生存率和总生存率分别为99%和100%。他们被认为是非恶性的,因此未对这些肿瘤的分期和等级进行进一步评估。在320例患者中至少确定了一项,最多确定了七个恶性预测参数。对于这些患者,其5年无病生存率和总生存率分别为44%(平均6.7年)和60%(平均9.3年)。无病生存期显示有无总扩散的患者之间有显着差异(PP = 0.0009)。无疾病扩散的患者的无病生存期和总生存期与恶性预测指标的数量有关(分别为PP = 0.882和0.441)。恶性胃肠道间质瘤可根据总扩散的不存在分为临床I期和II期。临床I期患者的恶性程度可根据恶性预测参数的数量进行分级。无论参数数量如何,处于临床II期的患者的恶性程度最高。我们发现临床阶段和等级与预后密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号